Bezos, Elon Musk and Zuckerberg Betting Big on S.C.G.
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More
Sanat Chattopadhyay, insider at Merck & Co., Inc.
Sanat Chattopadhyay Insider Alerts

Get notified the next time Sanat Chattopadhyay buys or sells Merck & Co., Inc. stock. Enter your email address below to get our daily insider buying and selling report.

Sanat Chattopadhyay Insider Information

Insider of Merck & Co., Inc.
Sanat Chattopadhyay is executive vice president and president, Merck Manufacturing Division. He has responsibility for the company’s worldwide manufacturing and supply operations across a global network of sites for pharmaceuticals, vaccines, biologics and animal health products.

A proven leader in the biopharmaceutical industry, Sanat joined Merck in November 2009 as senior vice president of global vaccines and sterile manufacturing operations, spearheading the transformation of manufacturing and supply chain to grow and globalize its vaccine business. Under Sanat’s leadership, Merck is currently executing significant expansion of its biologics and vaccines manufacturing capacity to reach more patients around the globe.

Before joining Merck, he served as senior vice president, technical operations and product supply, for Wyeth Pharmaceuticals, with responsibility for product supply, process development and operational excellence. Previously, he worked at Aventis and its predecessor companies as senior vice president, industrial operations, having served in many positions with increasing responsibilities for global supply chain, technology and manufacturing sites across North America, Europe and Asia Pacific.

A graduate chemical engineer from Jadavpur University and post-graduate industrial engineer from NITIE, India, Sanat is widely travelled, having lived with his family in five countries across three continents.

What is Sanat Chattopadhyay's net worth?

The estimated net worth of Sanat Chattopadhyay is at least $7.70 million as of February 12th, 2019. Mr. Chattopadhyay owns 95,343 shares of Merck & Co., Inc. stock worth more than $7,698,947 as of January 20th. This net worth estimate does not reflect any other assets that Mr. Chattopadhyay may own. Learn More.

What is Sanat Chattopadhyay's salary?

As the Insider of Merck & Co., Inc., Mr. Chattopadhyay earned a total compensation package of $4,946,155.00 in 2020. Mr. Chattopadhyay earned a salary of $805,046.00, stock awards of $1,916,154.00, options awards of $839,840.00, non-equity compensation of $645,975.00, and other compensation of $107,579.00.

How do I contact Sanat Chattopadhyay?

The corporate mailing address for Mr. Chattopadhyay and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at [email protected]

Has Sanat Chattopadhyay been buying or selling shares of Merck & Co., Inc.?

Sanat Chattopadhyay has not been actively trading shares of Merck & Co., Inc. in the last ninety days. Most recently, Sanat Chattopadhyay sold 24,619 shares of the business's stock in a transaction on Friday, October 29th. The shares were sold at an average price of $87.32, for a transaction totalling $2,149,731.08.

Who are Merck & Co., Inc.'s active insiders?

Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Richard Deluca (EVP), Kenneth Frazier (Insider), Julie Gerberding (EVP), Rita Karachun (VP), and Caroline Litchfield (CFO).

Are insiders buying or selling shares of Merck & Co., Inc.?

During the last year, insiders at the sold shares 8 times. They sold a total of 956,108 shares worth more than $80,196,014.36. The most recent insider tranaction occured on November, 9th when insider Kenneth C Frazier sold 663,881 shares worth more than $54,610,851.06. Insiders at Merck & Co., Inc. own 0.3 % of the company.

Information on this page was last updated on 11/9/2021.

Sanat Chattopadhyay Insider Trading History at Merck & Co., Inc.

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/29/2021Sell24,619$87.32$2,149,731.08View SEC Filing Icon  
8/13/2020Sell10,380$83.01$861,643.80View SEC Filing Icon  
2/12/2019Sell73,727$78.62$5,796,416.7495,343View SEC Filing Icon  
8/3/2018Sell29,208$65.20$1,904,361.6070,675View SEC Filing Icon  
See Full Table

Sanat Chattopadhyay Buying and Selling Activity at Merck & Co., Inc.

This chart shows Sanat Chattopadhyay's buying and selling at Merck & Co., Inc. by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Merck & Co., Inc. Company Overview

Merck & Co., Inc. logo
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
Read More

Today's Range

Now: $80.75
Low: $80.52
High: $81.86

50 Day Range

MA: $78.09
Low: $72.28
High: $84.11

2 Week Range

Now: $80.75
Low: $70.89
High: $91.40

Volume

12,063,892 shs

Average Volume

12,837,257 shs

Market Capitalization

$203.97 billion

P/E Ratio

28.53

Dividend Yield

3.40%

Beta

0.49
Grow Your Retirement Account With This Trade!
Whether you’re close to retirement or have barely begun your career, "How To Master the Retirement Trade" by expert Dave Aquino is the guide you’ve been waiting for.

Take advantage of a little known trade window and watch retirement come sooner than you ever thought possible.
Get your copy now!